Evaluation of biodegradable microspheres containing nomegestrol acetate in a rat model of endometriosis

Zhang J, Jianfeng Zhang, Zhu Y, Yan Zhu, Xianying Zhou, Zhou X, Shufang Hao, Hao S, Xie S, Shuwu Xie, Zhou J, Jieyun Zhou, Xiangjie Guo, Guo X, Zhao Li, Li Zhao, Li Z, Yun‐Sheng Huang, Yunsheng Huang, Qinghua Chen, Chen Q
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2014 · vol. 65 , pp. 15–20 · doi:10.1016/j.ejps.2014.08.011 · PMID:25201168 · W2068979870
article OA: closed CC0 ⤵ 5 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This study evaluated biodegradable microspheres containing nomegestrol acetate for their efficacy in a rat model of endometriosis, assessing their impact on the condition.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

We assessed the efficacy of biodegradable microspheres (MSs) containing nomegestrol acetate (NOMAC) for treatment of endometriosis in a rat model and investigated its preliminary mechanism of action. Sprague-Dawley rats with surgically implanted endometrial autografts were divided randomly into four groups of thirteen rats each, and subcutaneously injected twice (10d apart) with either empty MSs or MSs containing nomegestrol acetate (NOMAC-MS; 27-800mg per kg of rat body weight). Twenty-one days after the first injection, blood and endometriotic tissues were collected and assayed for changes in endometriotic tissue, serum hormone, liver function parameters, and apoptotic protein. No remarkable irritation was observed at the site of injection. NOMAC-MS treatment significantly reduced the volume of the endometrial autografts, decreased serum levels of estradiol, progesterone, triiodothyronine, and alanine aminotransferase, and decreased levels of estrogen receptor alpha protein. Furthermore, NOMAC-MS at the highest dose significantly reduced serum aspartate aminotransferase and endometrial antibody, reduced the Bcl-2/Bax protein ratio, and increased caspase-3 and caspase-9 proteins. There was no pronounced difference observed in alkaline phosphatase, carbohydrate antigen 125, progesterone receptor, or vascular endometrial growth factor receptor 2 (VEGFR2) in any of the tested groups relative to the control. NOMAC-MS significantly changed the expression of apoptotic protein only at the highest dose. Our findings warrant the further investigation of sustained application of steroid hormone via microspheres for the treatment of endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Megestrol Norpregnadienes Alanine Transaminase Alanine Transaminase Animals bcl-2-Associated X Protein bcl-2-Associated X Protein Caspase 3 Caspase 3 Caspase 9 Caspase 9 Disease Models, Animal Endometriosis Endometriosis Estradiol Estradiol Estrogen Receptor alpha Estrogen Receptor alpha Female

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (26)

Cited by (5)

Source provenance

europepmc
last seen: 2026-08-16T09:21:09.727480+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:18:15.805398+00:00
unpaywall
last seen: 2026-08-16T06:22:10.609676+00:00
License: CC0 · commercial use OK